New research techniques have improved the ability of evidence-based medicine to screen and stage for prostate cancer—helping to reduce needless and often painful procedures that were common practice just a decade ago.

  • 3T MRI, a less invasive and far more accurate tool for cancer detection than biopsy, is used with special imaging techniques to improve visualization of tumor nodes, as well as assessment of their precise location, risk, and aggressiveness.

  • MRI-TRUS fusion combines the benefits of MRI-guided biopsy with the less time-consuming, more cost-effective benefits of a transrectal ultrasound-guided (TRUS) biopsy. Data and anatomic detail provided by prostate MRI is electronically delivered to special fusion ultrasound machines. Physicians use that data to guide live, real-time ultrasound scanning.

Forward-Thinking Medicine

  • RadNet was one of the first imaging centers in the country to establish a dedicated Prostate MRI program.

  • Through the research efforts of Dr. Princenthal and Dr. Cohen, RadNet helped to establish the validity of multiparametric Prostate MRI as an evidence-based option to detect prostate cancer.

  • RadNet partners with some of the largist urology groups in the U.S., and we perform hundreds of Prostate MRI exams every week.

Prostate MRI Centers of Excellence